Alpha-lipoic acid protects against cholecystokinin-induced acute pancreatitis in rats

World J Gastroenterol. 2005 Aug 21;11(31):4883-5. doi: 10.3748/wjg.v11.i31.4883.

Abstract

Aim: Alpha-lipoic acid (ALA) has been used as an antioxidant. The aim of this study was to investigate the effect of alpha-lipoic acid on cholecystokinin (CCK)-octapeptide induced acute pancreatitis in rats.

Methods: ALA at 1 mg/kg was intra-peritoneally injected, followed by 75 microg/kg CCK-octapeptide injected thrice subcutaneously after 1, 3, and 5 h. This whole procedure was repeated for 5 d. We checked the pancreatic weight/body weight ratio, the secretion of pro-inflammatory cytokines and the levels of lipase, amylase of serum. Repeated CCK octapeptide treatment resulted in typical laboratory and morphological changes of experimentally induced pancreatitis.

Results: ALA significantly decreased the pancreatic weight/body weight ratio and serum amylase and lipase in CCK octapeptide-induced acute pancreatitis. However, the secretion of IL-1beta, IL-6, and TNF-alpha were comparable in CCK octapeptide-induced acute pancreatitis.

Conclusion: ALA may have a protective effect against CCK octapeptide-induced acute pancreatitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Cholecystokinin / antagonists & inhibitors
  • Cholecystokinin / toxicity*
  • Hyperlipidemias / prevention & control
  • Injections, Intraperitoneal
  • Interleukin-1 / metabolism
  • Interleukin-6 / metabolism
  • Male
  • Pancreatitis / prevention & control*
  • Rats
  • Rats, Wistar
  • Thioctic Acid / administration & dosage
  • Thioctic Acid / pharmacology*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-1
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Thioctic Acid
  • Cholecystokinin